Management consensus guideline for hepatocellular carcinoma: 2016 updated by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan

Autor: Sheng-Nan Lu, Jing-Houng Wang, Chien-Wei Su, Tsang-En Wang, Chia-Yen Dai, Chien-Hung Chen, Ran-Chou Chen, Sien-Sing Yang, Chien-Fu Hung, Shiu-Feng Huang, Li-Ying Liao, The-Ia Huo, Cheng-Chung Wu, Po-Huang Lee, Chin-Tsung Ting, Wei-Chen Lee, Gar-Yang Chau, Chih-Chi Wang, King-The Lee, Yi-Hsiang Huang, Ming-Chih Ho, Shi-Ming Lin, Guan-Tarn Huang, Kuan-Yang Chen, Xi-Zhang Lin, Jen-I. Hwang, Yi-You Chiou, Chung-Kwe Wang, Jui-Ting Hu, Shinn-Cherng Chen, Po-Chin Liang, Rheun-Chuan Lee, Ding-Kwo Wu, Cheng-Yao Lin, Chen-Chun Lin, Ann-Lii Cheng, Chiun Hsu, Yee Chao, Li-Tzong Chen, Po-Ming Wang, Ji-Hong Hong, Hsuan-Chih Hsu, Shang-Wen Chen, Stephen Wan Leung, Jason Chia-Hsien Cheng, Jaw-Ching Wu, Chun-Ying Wu, Yao-Chun Hsu, Chao-Wei Hsu, Yen-Hsuan Ni, Chih-Lin Lin
Jazyk: angličtina
Rok vydání: 2018
Předmět:
Zdroj: Journal of the Formosan Medical Association, Vol 117, Iss 5, Pp 381-403 (2018)
Druh dokumentu: article
ISSN: 0929-6646
DOI: 10.1016/j.jfma.2017.09.007
Popis: Background: Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related mortality in Taiwan. To help clinical physicians to manage patients with HCC, the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan produced the management consensus guideline for HCC. Methods: The recommendations focus on nine important issues on management of HCC, including surveillance, diagnosis, staging, surgery, local ablation, transarterial chemoembolization/transarterial radioembolization/hepatic arterial infusion chemotherapy, systemic therapy, radiotherapy, and prevention. Results: The consensus statements were discussed, debated and got consensus in each expert team. And then the statements were sent to all of the experts for further discussion and refinement. Finally, all of the experts were invited to vote for the statements, including the level of evidence and recommendation. Conclusion: With the development of the management consensus guideline, HCC patients could benefit from the optimal therapeutic modality. Keywords: Diagnosis, Hepatocellular carcinoma, Staging, Surveillance, Treatment
Databáze: Directory of Open Access Journals